OxyContin

Purdue Pharma, the manufacturer of the opioid painkiller OxyContin, is at the center of ongoing news due to its role in the prescription opioid crisis. The company is newsworthy as it faces sentencing in a criminal opioids case, a step that will allow settlement money to flow to victims and states. However, many opioid victims may be shut out of the Purdue settlement, causing frustration and raising questions about compensation distribution. ProPublica and The Philadelphia Inquirer are investigating how individual opioid victims have been compensated by court-appointed trusts funded by Purdue and other opioid manufacturers. The sentencing and settlement finalization are significant because they represent a step towards accountability for Purdue Pharma's actions and potential relief for communities and individuals affected by the opioid epidemic.